[1] Hollingsworth HC, kohn EC, Steinberg SM, et al. Tumor angiogenesis in advanced stage ovarian carcinoma[J]. Am J Pathol, 1995,147: 33-41. [2] 李元敏节译(原文只有此著者权项).血管生成,抗血管生成及靶向血管的基因治疗[J].国外医学·药学分册(Foreiyn Med.Pharmaco Sec),1995,22(5):285-9. [3] Assimakopoulou M, Sotiropoulou-Bouikou G, Miraxiotis T, et al.Microvessel density in brain tumors[J]. Anticancer Res, 1997, 17:4747-53. [4] Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment [J].Science, 1985, 230: 1375-8. [5] 谢守珍,顾美皎,程冀平,等.醋酸甲羟孕酮对恶性肿瘤诱导血管形成的抑制作用[J].中华妇产科杂志(Chin J Obstet Gynecol),1998,33(2):113-4. [6] 刘炳亚,林言箴,尹浩然,等.血管生成抑制剂TNP-470对胃癌生长及转移抑制作用的实验研究[J].中华肿瘤杂志,1998,20(1):34-6.Liu BY, Lin YZ, Yin HR, et al. Experimental study of the effect of angiogenesis inhibitor TNP-470 on the growth and metastasis of gastric[J]. Chin J Oncol, 1998, 20(1): 34-6. [7] Ashino-Fuse H, Takano Y, Oikawa T, et al. Medroxyprogesterone acetate, an anticancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cell[J]. Int J Cancer, 1989,44: 859-63. [8] 胡琢瑛,邓晓谷.孕激素对人卵巢癌细胞株HO8910细胞增殖及凋亡的影响[J].中华妇产科杂志,2000,35(7):423-6.Hu ZY, Deng XG. The effect of progesterone on proliferation and apoptosis in ovarian cancer cell [J]. Chin J Obstet Gynecol, 2000,35(7): 423-6. [9] 谢守珍,王晶,曹亚莉,等.晚期卵巢恶性肿瘤术后辅助化学治疗及醋酸甲羟孕酮的临床观察[J].中华妇产科杂志(Chin J Obstet Gynecol),2000,35(10):625-6. |